IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Osiris Therapeutics Inc New

CUSIP: 68827R10 | 3 institutional holders

Quarters

Q2 2015Q2 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2015

Arrowstreet Capital, Limited Partnership47,112
0.0% of portfolio›$917
Northern Trust Corp13,690
0.0% of portfolio›$266
StyleTurnoverLocationFiled
Arrowstreet Capital, Limited Partnership
47,112$9170.0%GARPHighBoston, MA2015-08-13
Northern Trust Corp
13,690$2660.0%IndexVery LowChicago, IL2015-08-13